Working… Menu

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01974661
Recruitment Status : Completed
First Posted : November 1, 2013
Last Update Posted : September 29, 2017
Uppsala University
Information provided by (Responsible Party):
Immunicum AB

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 28, 2017
Actual Study Completion Date : June 28, 2017